These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28698973)

  • 1. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women.
    Martínez ME; Gomez SL; Tao L; Cress R; Rodriguez D; Unkart J; Schwab R; Nodora JN; Cook L; Komenaka I; Li C
    Breast Cancer Res Treat; 2017 Nov; 166(1):185-193. PubMed ID: 28698973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
    Banegas MP; Tao L; Altekruse S; Anderson WF; John EM; Clarke CA; Gomez SL
    Breast Cancer Res Treat; 2014 Apr; 144(3):625-34. PubMed ID: 24658879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.
    Parise CA; Caggiano V
    BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women.
    Keegan TH; Press DJ; Tao L; DeRouen MC; Kurian AW; Clarke CA; Gomez SL
    Breast Cancer Res; 2013; 15(5):R95. PubMed ID: 24131591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.
    Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN
    Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.
    Connor AE; Visvanathan K; Baumgartner KB; Baumgartner RN; Boone SD; Hines LM; Wolff RK; John EM; Slattery ML
    Breast Cancer Res Treat; 2017 Jan; 161(2):321-331. PubMed ID: 27837379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 status and disparities in luminal breast cancers.
    Holowatyj AN; Ruterbusch JJ; Ratnam M; Gorski DH; Cote ML
    Cancer Med; 2016 Aug; 5(8):2109-16. PubMed ID: 27250116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
    Tao L; Gomez SL; Keegan TH; Kurian AW; Clarke CA
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1039-45. PubMed ID: 25969506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.
    Patel MI; Schupp CW; Gomez SL; Chang ET; Wakelee HA
    J Clin Oncol; 2013 Oct; 31(28):3572-8. PubMed ID: 23960183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system.
    Keegan TH; Kurian AW; Gali K; Tao L; Lichtensztajn DY; Hershman DL; Habel LA; Caan BJ; Gomez SL
    Am J Public Health; 2015 May; 105(5):938-46. PubMed ID: 25790426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women.
    Hines LM; Risendal B; Byers T; Mengshol S; Lowery J; Singh M
    J Womens Health (Larchmt); 2011 Oct; 20(10):1543-50. PubMed ID: 21721934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.
    Zhang L; King J; Wu XC; Hsieh MC; Chen VW; Yu Q; Fontham E; Loch M; Pollack LA; Ferguson T
    Cancer Epidemiol; 2019 Feb; 58():1-7. PubMed ID: 30415099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
    Nahleh Z; Otoukesh S; Mirshahidi HR; Nguyen AL; Nagaraj G; Botrus G; Badri N; Diab N; Alvarado A; Sanchez LA; Dwivedi AK
    Cancer Med; 2018 Jun; 7(6):2710-2717. PubMed ID: 29733543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
    Parise C; Caggiano V
    Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding melanoma burden in California hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location.
    Pollitt RA; Clarke CA; Swetter SM; Peng DH; Zadnick J; Cockburn M
    Cancer; 2011 Jan; 117(1):152-61. PubMed ID: 20737564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
    Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
    Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
    Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
    J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.